Denmark-based cancer diagnostics solutions manufacturer Dako announced that it has entered into collaboration agreement with Pfizer in the field of companion diagnostics. The agreement includes a legal framework for various collaboration ...
Tags: cancer diagnostics solutions, Dako, Pfizer
Bristol-Myers Squibb has reached an agreement with Reckitt Bencksier for several of its over-the-counter medicines. As part of the agreement, Reckitt Benckiser will pay Bristol-Myers Squibb $438 million (£282 million) upfront for ...
SlideShare, a presentation-sharing site used primarily by professionals, has added a premium feature that lets members closely monitor usage of their presentations. The detailed analytics data is intended to help presentation owners in ...
Pfizer has obtained FDA approval for the expanded use of Prevnar 13, pneumococcal conjugate vaccine, in children and adults between six to 17 years of age who are new to the vaccine. The single dose Pneumococcal 13-valent conjugate ...
Tags: FDA, vaccine, conjugate vaccine
Pfizer's bosutinib has received positive opinion for the conditional marketing authorization from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). The bosutinib positive CHMP opinion is concerned with ...
Pfizer has announced the availability of attention deficit hyperactivity disorder (ADHD) therapy, Quillivant XR (methylphenidate hydrochloride) CII for extended-release oral suspension, in the US. The extended-release liquid ...
Tags: Pfizer, ADHD therapy, Quillivant XR CII
Check your prescription container to see if a manufacturer is listed on the label. If your bottle says "Ranbaxy," call or take it back to the pharmacy where you filled the prescription to find out if it's been recalled. The pharmaceutical ...
Tags: prescription container, pharmacy, healthcare, recall
Pfizer has obtained the European Commission approval for the use of Prevenar 13 vaccine in older children and adolescents aged six to 17 years for the prevention of pneumococcal disease. Single dose of the pneumococcal conjugate vaccine ...
Tags: vaccine, Pfizer, pneumococcal disease, medicines
Nestle has declined to comment on a report claiming it could sell US$1bn of assets in Latin America in order to secure final regulatory approvals for its Pfizer nutrition unit acquisition. Nestle is looking to sell the assets to ...
Tags: Nestle, sale report, nutrition acquisition, nutrition
EMD Serono, a subsidiary of Merck, and Pfizer have announced the FDA approval of Rebif Rebidose (interferon beta-1a) for the treatment of relapsing forms of multiple sclerosis (MS). Rebif Rebidose was designed as single-use auto-injector ...
Bristol-Myers Squibb and Pfizer have announced the US FDA's approval for Eliquis (apixaban), used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. In 2007, Pfizer and Bristol-Myers ...
Tags: US, FDA, Eliquis, patients, nonvalvular atrial fibrillation
Mylan's subsidiary Mylan Pharmaceuticals has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Phenytoin Chewable Tablets USP, 50 mg. Phenytoin is the generic ...
Tags: Mylan, Mylan Pharmaceuticals, US, FDA, ANDA, Phenytoin Chewable Tablets
Repligen has announced a new licensing agreement with Pfizer in an effort to advance Repligen's spinal muscular atrophy (SMA) program. The work focuses on RG3039, which is a small molecule drug candidate in clinical development for the ...
Tags: Repligen, Pfizer, spinal muscular atrophy, Medicine
Bristol-Myers Squibb and Pfizer have announced the approval of Eliquis (apixaban) anticoagulant for the prevention of ischemic stroke and systemic embolism in patients suffering from nonvalvular atrial fibrillation (NVAF) in Japan. The ...
Tags: Japan, approval, anticoagulant, subanalysis
Halozyme Therapeutics has entered into collaboration and license agreement with Pfizer for the development and commercialization of subcutaneous biologics. The collaboration will focus on developing Pfizer biologics, leveraging Halozyme's ...
Tags: biologics, Halozyme Therapeutics, subcutaneous biologics, treatments